Search Ask TB Research About

← Back to search

Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis*

Mason, Elizabeth, Russell, D. W.

Abstract

No abstract available.

Document

TB Research ID: tbrsch_1971_who_262710
Type: Research article
TB subtype: Unspecified
Peer reviewed: Yes
Language: EN
License: who-iris-cc-by-nc-sa-3.0-igo (perm. 1)

Cite this

Canonical source: PubMed 10665/262710

Ask TB Research

Ask a question grounded in this and related documents from the corpus.

Ask about this paper →

v0.2 · PubMed · Europe PMC · ClinicalTrials.gov · OpenAlex · code Apache 2.0 · corpus metadata CC0

PubMed · WHO Global TB

Related papers

Isoniazid acetylation phenotypes in the Sudanese population; findings and implicationsMonadil H. Ali, Alian A. Alrasheedy et al. · 2019
Isoniazid acetylation phenotypes in the Sudanese population; findings and implicationsAli MH, Alrasheedy AA et al. · 2019
Clinical Prediction of Acetylator Phenotype in Tuberculosis Patients on Medicare using Blood GroupJamey Peters Mairiga, M.C. UKEAGBU et al. · 2022
Population Pharmacokinetics Model Development of Isoniazid for Individualizing Tuberculosis Treatment Based on the NAT2 Acetylator PhenotypeNguyen Phuoc Long, Yumi Park et al. · 2020
NAT2 Gene Polymorphisms and Plasma Isoniazid Concentration in Vietnamese Tuberculosis PatientsTuấn Anh Lê, Nhung H. Pham et al. · 2021